NLM Digital Collections

Search

Start Over Subjects Antibodies, Monoclonal ✖Remove constraint Subjects: Antibodies, Monoclonal Authors Rind, David M., author ✖Remove constraint Authors: Rind, David M., author Titles Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report ✖Remove constraint Titles: Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report

1. Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report

Author(s):
Rind, David M., author
Walton, Surrey M., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Quach, Danny, author
Chapman, Rick M., author
Pearson, Steven D., author
Bradt, Pamela, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 20, 2020
Subject(s):
Antibodies, Monoclonal
Genetic Therapy
Hemophilia A -- drug therapy
United States

Refine by:

more »

  • Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report1